Literature DB >> 28473088

ACR Appropriateness Criteria® Suspected Liver Metastases.

Harmeet Kaur1, Nicole M Hindman2, Waddah B Al-Refaie3, Hina Arif-Tiwari4, Brooks D Cash5, Victoria Chernyak6, James Farrell7, Joseph R Grajo8, Jeanne M Horowitz9, Michelle M McNamara10, Richard B Noto11, Aliya Qayyum12, Tasneem Lalani13, Ihab R Kamel14.   

Abstract

Liver metastases are the most common malignant liver tumors. The accurate and early detection and characterization of liver lesions is the key to successful treatment strategies. Increasingly, surgical resection in combination with chemotherapy is effective in significantly improving survival if all metastases are successfully resected. MRI and multiphase CT are the primary imaging modalities in the assessment of liver metastasis, with the relative preference toward multiphase CT or MRI depending upon the clinical setting (ie, surveillance or presurgical planning). The optimization of imaging parameters is a vital factor in the success of either modality. PET/CT, intraoperative ultrasound are used to supplement CT and MRI. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer-reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Copyright © 2017 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AUC; Appropriate Use Criteria; Appropriateness Criteria; MRI; PET/CT; liver metastasis imaging; liver metastasis surveillance; liver presurgical staging; multidetector CT

Mesh:

Year:  2017        PMID: 28473088     DOI: 10.1016/j.jacr.2017.01.037

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  8 in total

Review 1.  Computed Tomography Versus Magnetic Resonance Imaging for Hepatic Lesion Characterization/Diagnosis.

Authors:  Khaled Y Elbanna; Ania Z Kielar
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

2.  Detection of liver metastases on gadobenate dimeglumine-enhanced MRI: systematic review, meta-analysis, and similarities with gadoxetate-enhanced MRI.

Authors:  Ling Zhang; Xian Yu; Lei Huo; Lun Lu; Xinpeng Pan; Ningyang Jia; Xinxiang Fan; Giovanni Morana; Luigi Grazioli; Guenther Schneider
Journal:  Eur Radiol       Date:  2019-03-26       Impact factor: 5.315

Review 3.  Updates on Imaging of Liver Tumors.

Authors:  Arya Haj-Mirzaian; Ana Kadivar; Ihab R Kamel; Atif Zaheer
Journal:  Curr Oncol Rep       Date:  2020-04-16       Impact factor: 5.075

4.  Diagnostic accuracy of non-contrast abdominopelvic computed tomography scans in follow-up of breast cancer patients.

Authors:  Sang Yu Nam; Su Joa Ahn; Young Rock Jang; Yong Soon Chun; Heung Kyu Park; Seung Joon Choi; Hye Young Choi; Jeong Ho Kim
Journal:  Br J Radiol       Date:  2020-12-11       Impact factor: 3.039

5.  Regression patterns of choroidal melanoma: After palladium-103 (103Pd) plaque brachytherapy.

Authors:  Abhilasha Maheshwari; Paul T Finger
Journal:  Eur J Ophthalmol       Date:  2018-05-22       Impact factor: 2.597

6.  The added diagnostic value of complementary gadoxetic acid-enhanced MRI to 18F-DOPA-PET/CT for liver staging in medullary thyroid carcinoma.

Authors:  Daniel Puhr-Westerheide; Clemens C Cyran; Josef Sargsyan-Bergmann; Andrei Todica; Franz-Josef Gildehaus; Wolfgang G Kunz; Robert Stahl; Christine Spitzweg; Jens Ricke; Philipp M Kazmierczak
Journal:  Cancer Imaging       Date:  2019-11-14       Impact factor: 3.909

7.  Total Bilirubin Level as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer.

Authors:  Jeong Ah Hwang; Ji Hye Min; Seong Hyun Kim; Seo-Youn Choi; Ji Eun Lee; Ji Yoon Moon
Journal:  Korean J Radiol       Date:  2022-01-04       Impact factor: 3.500

Review 8.  Colorectal liver metastases: Current management and future perspectives.

Authors:  Jack Martin; Angelica Petrillo; Elizabeth C Smyth; Nadeem Shaida; Samir Khwaja; H K Cheow; Adam Duckworth; Paula Heister; Raaj Praseedom; Asif Jah; Anita Balakrishnan; Simon Harper; Siong Liau; Vasilis Kosmoliaptsis; Emmanuel Huguet
Journal:  World J Clin Oncol       Date:  2020-10-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.